#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2880	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2478	342.8	0	.	n	.	0	C207T	SNP	207	207	C	607	607	T	396	T,C	175,166	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2880	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2478	342.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1850	1850	T	425	T,C	194,208	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2880	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2478	342.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1584	1584	C	405	C	373	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2880	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2478	342.8	0	HET	.	.	.	C451T	.	451	451	C	851	851	C	410	C,T	202,174	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2880	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2478	342.8	0	HET	.	.	.	C328G,T	.	328	328	C	728	728	C	386	C,G,T	251,105,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4668	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4012	348.2	0	.	n	.	0	T695C	SNP	695	695	T	1225	1225	C	345	C	314	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4668	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4012	348.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2501	2501	C	392	C,T	361,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4668	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4012	348.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3127	3127	T	380	T,C	345,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4668	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4012	348.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2575	2575	A	403	A	366	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	438	folP	855	855	100.0	folP.l15.c4.ctg.1	2257	58.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1392	1394	AGC	78;79;78	A;G;C	73;75;72	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	874	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4021	65.2	1	SNP	p	S91F	1	.	.	271	273	TTC	927	929	TTC	86;86;86	T;T;C,T	82;82;80,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	874	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4021	65.2	1	SNP	p	G95N	0	.	.	283	285	GGC	939	941	GGC	80;81;81	G;G;C	75;76;78	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	874	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4021	65.2	1	SNP	p	D95G	1	.	.	283	285	GGC	939	941	GGC	80;81;81	G;G;C	75;76;78	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	360	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1910	56.5	1	SNP	p	G45D	0	.	.	133	135	GGC	777	779	GGC	95;95;95	G;G;C	85;85;86	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	248	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1613	46.2	0	.	n	.	0	A197.	DEL	197	197	A	882	882	A	98	A	93	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1056	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3417	92.3	1	SNP	p	D86N	0	.	.	256	258	GAC	885	887	GAC	120;121;123	G;A;C	102;104;109	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1056	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3417	92.3	1	SNP	p	R87I	0	.	.	259	261	CGT	888	890	CGT	126;126;125	C;G;T	112;113;110	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1056	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3417	92.3	1	SNP	p	S87R	1	.	.	259	261	CGT	888	890	CGT	126;126;125	C;G;T	112;113;110	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1056	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3417	92.3	1	SNP	p	R87W	0	.	.	259	261	CGT	888	890	CGT	126;126;125	C;G;T	112;113;110	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1056	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3417	92.3	1	SNP	p	S88P	0	.	.	262	264	TCC	891	893	TCC	124;124;123	T;C;C	103;114;109	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	832	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3081	80.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1859	1861	GGC	96;94;94	G;G;C	86;83;83	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	734	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2880	76.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1500	1502	GCC	88;88;87	G;C;C	82;79;80	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	734	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2880	76.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1503	1505	ATG	87;87;87	A;T;G	82;82;77	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	734	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2880	76.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1515	1517	ACC	91;91;91	A;C;C	85;82;81	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	734	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2880	76.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1515	1517	ACC	91;91;91	A;C;C	85;82;81	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	734	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2880	76.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2016	2018	ACC	97;97;95	A;C;C	84;84;84	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	734	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2880	76.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2070	2072	GCG	90;90;90	G;C;G	80;80;79	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	734	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2880	76.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2070	2072	GCG	90;90;90	G;C;G	80;80;79	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	734	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2880	76.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2193	2195	GGT	99;98;98	G;G,A;T	93;90,1;87	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	734	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2880	76.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2202	2204	AGC	99;99;99	A;G;C	91;92;93	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	734	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2880	76.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2220	2222	CCG	95;95;95	C;C;G	79;82;82	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1020	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3568	85.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1820	1822	CCG	97;98;100	C;C;G	87;90;92	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	592	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2141	82.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	721	721	C	97	C	87	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	512	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	2684	56.8	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1161	1163	AGA	99;99;101	A;G,A;A	91;88,1;92	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	512	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	2684	56.8	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1182	1184	GGT	97;98;97	G;G;T	87;89;90	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	512	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	2684	56.8	1	SNP	p	G120K	1	.	.	358	360	AAG	891	893	AAG	122;122;121	A;A;G	115;110;104	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	512	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	2684	56.8	1	SNP	p	N121D	0	.	.	361	363	AAC	894	896	AAC	120;120;120	A;A;C,A	111;111;107,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	512	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	2684	56.8	1	SNP	p	A121N	1	.	.	361	363	AAC	894	896	AAC	120;120;120	A;A;C,A	111;111;107,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1744	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5269	98.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	316	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1632	57.8	1	SNP	p	V57M	1	.	.	169	171	ATG	789	791	ATG	111;111;111	A;T;G	98;103;101	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
